Creating a Complete View of Dermatology Care to Strengthen Brand and Portfolio Decisions to Drive Competitive Advantage

Head of U.S. Immunology at UCB. As Head of U.S. Immunology at UCB, Camille drives patient-focused strategies and business transformation to deliver value to those with autoimmune and inflammation-related diseases. Her leadership in launching UCB’s Bimzelx for psoriasis and HS, and other immunologic conditions highlights her ability to navigate complex regulatory environments while driving innovation and patient empowerment. With over 30 years in the pharmaceutical industry, Camille brings extensive expertise in marketing, managed markets, operations, strategic launch planning, and sales management, having led pivotal global and U.S. product launches.

Nandini Kashyap is Conference Director for Fierce Pharma/Biotech and founder of CenterStage Media, an events and marketing venture. Former scientist and a seasoned strategist and business connector, she has led 100+ global conferences and B2B events across pharma and biotech specializing in conference production, strategic partnerships and executive engagement, operations, thought leadership.  Previously, she served as Senior Director of Conferences & Social Media Strategy at Cambridge Innovation Institute and Director of Novel Drug Delivery at Biodel Inc.

Beyond conferences, Nandini is also a recognized life science ambassador and has been featured on campaigns for Novartis, Takeda, Philips, Dana-Farber, Werfen, and Salesforce and more. Ms. Kashyap holds a Master’s in Pharmaceutics from NIPER (India), a Bachelor’s in Pharmacy from New Delhi, and postgraduate certifications from Cornell (Marketing & Social Media Strategy) and MIT (Controlled Release Technologies).

Dr. Ghazanfar (Sunny) Khan is the Chief Medical Officer at Evidation. A physician and global health leader, he brings experience in clinical practice, public health, digital health innovation, and large-scale data integration. Before joining Evidation, he was Executive Director of Digital Health at Our Future Health, the UK’s largest health research program, where he led integration of data from more than a million participants. Previously, he was Head of Clinical at Mendelian, a digital health company advancing rare disease diagnosis within the NHS, and led global initiatives at the World Health Organization, including development of a digital platform that supported essential health services during the COVID-19 pandemic.  He was previously appointed as Visiting Scholar and Faculty Affiliate at Harvard Medical School’s Center for Primary Care, where his work focused on the use of patient-generated data in clinical decision-making.

Dr. Khan earned his medical degree with Honors from the University of Leeds, is a Member of the Royal College of General Practitioners, and holds a Master of Public Health with Distinction from the London School of Hygiene and Tropical Medicine.